Live Breaking News & Updates on Bradley Alexander Mcgregor

Stay updated with breaking news from Bradley alexander mcgregor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ASCO 2023: Solid Tumors

Coverage of clinical trial results presented across a range of solid tumor cancers, including breast, ovarian, colorectal, and non-small cell lung cancer, among other types; as well as important findings in genomic testing. ....

United States , University Of Chicago , New Haven , National Taiwan University , T Ai Pei , Long Wu , San Antonio , South Korea , Alpha Biopharma , Jie Wang , Dennisj Slamon , Debra Patt , Dennis Slamon , Borisa Hadaschik , Roys Herbst , Rita Nanda , Bradley Alexander Mcgregor , Nathan Pennell , Qing Zhou , Andrew Hertler , Mengzhao Wang , Daiichi Sankyo , Awny Farajallah , Jonathanw Riess , Tus Fruquintinib , Eli Lilly ,

T-DXd Active in Many Solid Tumors; 'Shift in Thinking'

The antibody-drug conjugate trastuzumab-deruxtecan was associated with high objective response rates among patients with a range of HER2-expressing solid tumors. ....

United States , Dana Farber Cancer Institute , Kohei Shitara , Julier Gralow , Bradley Alexander Mcgregor , American Society Of Clinical Oncology , National Cancer Center Hospital , University Of Texas Md Anderson Cancer Center , Funda Meric Bernstam , Cancer Center , American Society , Clinical Oncology , National Cancer Center Hospital East , Medscape Medical News , Breast Cancer , Alignant Breast Neoplasm , Biologic Therapy , Malignant Pancreatic Neoplasm , Pancreatic Cancer , Ancer Pancreatic , Endometrial Carcinoma , Bladder Cancer , Alignant Bladder Neoplasm , Cervical Cancer , Alignant Cervix Neoplasm , Ovarian Cancer ,

Trastuzumab Deruxtecan Brings Encouraging Responses in HER2-Expressing Cancers Across Multiple Tumor Types

In early findings, the antibody drug conjugate created strong responses in multiple tumor types where patients have unmet need. ....

United States , Bradley Alexander Mcgregor , American Society Of Clinical Oncology , Department Of Investigational Cancer Therapeutics , University Of Texas Md Anderson Cancer Center , American Society , Clinical Oncology , Funda Meric Bernstam , Investigational Cancer Therapeutics ,

Trastuzumab deruxtecan shows 'broad activity' in HER2-expressing solid tumors

CHICAGO — Trastuzumab deruxtecan showed clinically meaningful activity against several types of HER2-expressing solid tumors, according to interim results of the DESTINY-PanTumor02 study presented at ASCO Annual Meeting.The HER2-directed antibody-drug conjugate, also known as T-DXd (Enhertu; AstraZeneca, Daiichi Sankyo), demonstrated the highest objective response rates and most durable ....

Black Diamond , United States , Tyra Biosciences , Bydevin Mclaughlin , Devin Mclaughlin , Daiichi Sankyo , Bradley Alexander Mcgregor , University Of Texas Md Anderson Cancer Center , Infinity Pharmaceuticals , Menarini Group , Debiopharm Group , Apeiron Biologics , Black Diamond Therapeutics , Karyopharm Therapeutics , Lengo Therapeutics , Loxo Oncology , Oncusp Therapeutics , Silverback Therapeutics , Tallac Therapeutics , Cancer Center , Published June ,

Pembrolizumab Activity in BCG-Refractory Papillary Bladder Cancer

Pembrolizumab monotherapy showed promising antitumor activity for patients with high-risk non–muscle invasive bladder cancer that did not respond to standard treatment with BCG. ....

United States , Dana Farber Cancer Institute , Noord Holland , Andrea Necchi , Michiel Simon , Bradley Alexander Mcgregor , Lank Center , Scientific Institute , Salute San Raffaele University , American Society Of Clinical Oncology , Netherlands Cancer Institute , Vita Salute San Raffaele University , Raffaele Hospital , Genitourinary Cancers Symposium , American Society , Genitourinary Oncology , Prognosis After Relapse , Some Concerns , Bladder Cancer , Alignant Bladder Neoplasm , Radical Cystectomy Of The Bladder , Alignant Neoplasia , Biologic Therapy , Thyroid Disorder , Cystectomy Removal Ofa Cyst , Healthcare And Medical Technology ,